Published in C R Acad Sci Hebd Seances Acad Sci D on December 23, 1968
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature (1988) 3.59
Patterns of RNA metabolism in a differentiated cell: a rapidly labeled, unstable 60S RNA with messenger properties in duck erythroblasts. Proc Natl Acad Sci U S A (1966) 2.71
Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci U S A (1992) 2.17
A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell (1990) 1.89
High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood (1997) 1.79
Seizures of temporal lobe epilepsy: identification of subtypes by coherence analysis using stereo-electro-encephalography. Clin Neurophysiol (1999) 1.73
Pitfalls of high-pass filtering for detecting epileptic oscillations: a technical note on "false" ripples. Clin Neurophysiol (2009) 1.70
The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene (1989) 1.65
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol (1996) 1.63
Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature (1987) 1.59
Emergence of tumorigenic cells during the course of Friend virus leukemias. Proc Natl Acad Sci U S A (1981) 1.52
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest (1988) 1.48
Neural networks involving the medial temporal structures in temporal lobe epilepsy. Clin Neurophysiol (2001) 1.46
The physiopathology of Friend leukemia. Leuk Res (1979) 1.43
Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood (1993) 1.42
[Spatio-temporal dynamics of neuronal networks in partial epilepsy]. Rev Neurol (Paris) (2005) 1.42
Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus. Proc Natl Acad Sci U S A (1991) 1.40
[Study of rapidly labelled nuclear and cytoplasmic RNA in differentiated avian erythropoietic cells]. Bull Soc Chim Biol (Paris) (1966) 1.34
Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood (2000) 1.32
Production of erythropoietin-like activity by a murine erythroleukemia cell line. Proc Natl Acad Sci U S A (1983) 1.30
Pre-ictal synchronicity in limbic networks of mesial temporal lobe epilepsy. Epilepsy Res (2004) 1.25
[Somatic polyploid cells in rat liver. I. The role of binuclear cells in the formation of the polyploid cells]. Exp Cell Res (1966) 1.24
Malignant transformation and erythroid differentiation by polycythaemia-inducing Friend virus. Nat New Biol (1971) 1.21
Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood (1990) 1.20
The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood (1995) 1.20
Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs. Oncogene (1990) 1.18
Two consecutive nationwide outbreaks of Listeriosis in France, October 1999-February 2000. Am J Epidemiol (2001) 1.18
Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias. Leukemia (1990) 1.15
Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome. Blood (2000) 1.12
Role of p21(Cip1/Waf1) in cell-cycle exit of endomitotic megakaryocytes. Blood (2001) 1.09
Target cell for oncogenic action of polycythaemia-inducing Friend virus. Nature (1975) 1.09
Induction of the autonomous stage of transformation in erythroid cells infected with SFFV: helper virus is not required. Virology (1986) 1.08
5-Methoxypsoralen, the melanogenic additive in sun-tan preparations, is tumorigenic in mice exposed to 365 nm u.v. radiation. Carcinogenesis (1981) 1.07
A method to identify reproducible subsets of co-activated structures during interictal spikes. Application to intracerebral EEG in temporal lobe epilepsy. Clin Neurophysiol (2005) 1.04
The murine M-CSF gene is localized on chromosome 3. Blood (1989) 1.03
Identification of tissues and cells producing erythropoietin in the anemic mouse. Contrib Nephrol (1988) 1.03
Oncogenicity of Friend-virus-infected cells: determination of origin of spleen colonies by the H-2 antigens as genetic markers. Int J Cancer (1978) 1.01
Erythrocyte production in mice infected by the polycythaemia-inducing Friend virus or by the anaemia-inducing Friedn virus. Br J Haematol (1973) 0.98
Fertile dominant spotting in the house mouse. J Hered (1979) 0.98
MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology (1986) 0.98
Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors. Leukemia (1989) 0.96
Carcinogenicity of chloroethylene oxide, an ultimate reactive metabolite of vinyl chloride, and bis(chloromethyl)ether after subcutaneous administration and in initiation-promotion experiments in mice. Cancer Res (1980) 0.95
Effect of prevention measures on incidence of human listeriosis, France, 1987-1997. Emerg Infect Dis (2001) 0.94
Friend leukemia as a multiple-step disease. Blood Cells (1981) 0.93
Integration of spleen focus-forming virus proviruses in Friend tumor cells. J Virol (1985) 0.92
Characterization of erythropoietin produced by IW32 murine erythroleukemia cells. Blood (1984) 0.92
The neuronal sources of EEG: modeling of simultaneous scalp and intracerebral recordings in epilepsy. Neuroimage (2008) 0.91
Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. Leukemia (1990) 0.91
Production of erythropoietin by cloned malignant murine erythroid cells. Exp Hematol (1985) 0.91
Ultraviolet light induction of skin carcinoma in the mouse; influence of cAMP modifying agents. Bull Cancer (1978) 0.90
Factor-independent erythropoietic progenitor cells in leukemia induced by the myeloproliferative leukemia virus. Blood (1989) 0.89
Analysis of integrated proviral DNA sequences with an octadecanucleotide probe designed for specific identification of spleen focus-forming virus in the mouse genome. J Virol (1986) 0.89
Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood (1996) 0.88
Target cell of the polycythemia-inducing Friend virus: studies with myleran. J Natl Cancer Inst (1975) 0.86
[Effect of different erythropoietic homeostasis factors on the evolution of Friend's leukemia]. Nouv Rev Fr Hematol (1970) 0.86
Interferon and murine leukaemia. 3. Efficacy of interferon preparations administered after inoculation of Friend virus. Nature (1967) 0.85
Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation. Oncogene (1998) 0.85
Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice. Br J Dermatol (1979) 0.85
Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives. J Med Chem (1980) 0.85
A self-renewing, bipotential erythroid/mast cell progenitor in continuous cultures of normal murine bone marrow. J Cell Physiol (1985) 0.84
[The concept of an epileptogenic network in human partial epilepsies]. Neurochirurgie (2008) 0.83
Realistic modeling of entorhinal cortex field potentials and interpretation of epileptic activity in the guinea pig isolated brain preparation. J Neurophysiol (2006) 0.83
Expression of c-ras and c-myc oncogenes in murine erythroleukemias induced by Friend viruses. Leuk Res (1984) 0.83
Megakaryocytopoiesis: cellular aspects and regulation. Crit Rev Oncol Hematol (1995) 0.83
Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette. Leukemia (2001) 0.82
Erythropoietin: sites of synthesis and regulation of secretion. Am J Kidney Dis (1991) 0.82
Autocrine stimulation by erythropoietin (Epo) requires Epo secretion. Blood (1994) 0.82
Three-dimensional computer morphometry of the maxilla and face in infants with Pierre Robin sequence--a comparative study. Cleft Palate Craniofac J (2000) 0.82
Production of high plasma levels of erythropoietin in mice. Biomedicine (1973) 0.81
Comparison of two estimators of time-frequency interdependencies between nonstationary signals: application to epileptic EEG. Conf Proc IEEE Eng Med Biol Soc (2004) 0.81
Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2. Cell Growth Differ (1996) 0.81
Genetic analysis of myeloproliferative leukemia virus, a novel acute leukemogenic replication-defective retrovirus. J Virol (1987) 0.81
High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin. Blood (1999) 0.81
Solubilization and hydrodynamic characteristics of the erythropoietin receptor. Evidence for a multimeric complex. Eur J Biochem (1990) 0.81
Wavelet analysis of EEG for three-dimensional mapping of epileptic events. Ann Biomed Eng (1996) 0.81
Carcinogenic activity in situ of further steroid compounds. Nature (1966) 0.80
The 'WS motif' common to v-mpl and members of the cytokine receptor superfamily is dispensable for myeloproliferative leukemia virus pathogenicity. Oncogene (1993) 0.80
Neural networks underlying hyperkinetic seizures of "temporal lobe" origin. Epilepsy Res (2009) 0.80
[Hepatic polyploidy in the rat. IV. Experimental changes in the nucleolar volume of liver cells and their mechanisms of regulation]. Exp Cell Res (1967) 0.80
[Inhibitory effect of caffeine on the induction of cutaneous cancers by ultraviolet rays in the mouse]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.80